Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 15 studies | 89% ± 14% | |
| glutamatergic neuron | 12 studies | 83% ± 17% | |
| GABAergic neuron | 11 studies | 68% ± 25% | |
| microglial cell | 9 studies | 33% ± 20% | |
| endothelial cell | 7 studies | 43% ± 21% | |
| oligodendrocyte | 7 studies | 37% ± 26% | |
| retinal ganglion cell | 6 studies | 68% ± 29% | |
| astrocyte | 5 studies | 44% ± 26% | |
| neuron | 4 studies | 41% ± 23% | |
| OFF-bipolar cell | 4 studies | 58% ± 27% | |
| interneuron | 4 studies | 85% ± 19% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 75% ± 3% | |
| GABAergic interneuron | 3 studies | 80% ± 15% | |
| retinal pigment epithelial cell | 3 studies | 63% ± 25% | |
| GABAergic amacrine cell | 3 studies | 42% ± 7% | |
| ON-bipolar cell | 3 studies | 54% ± 28% | |
| glycinergic amacrine cell | 3 studies | 53% ± 19% | |
| rod bipolar cell | 3 studies | 61% ± 28% | |
| amacrine cell | 3 studies | 60% ± 18% | |
| granule cell | 3 studies | 79% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 5244.13 | 2604 / 2642 | 97% | 25.81 | 682 / 705 |
| kidney | 1% | 4.69 | 1 / 89 | 30% | 2.53 | 271 / 901 |
| adrenal gland | 1% | 6.96 | 2 / 258 | 27% | 2.44 | 61 / 230 |
| thymus | 2% | 7.09 | 11 / 653 | 25% | 2.68 | 149 / 605 |
| spleen | 23% | 89.34 | 55 / 241 | 0% | 0 | 0 / 0 |
| breast | 4% | 18.11 | 20 / 459 | 10% | 0.26 | 111 / 1118 |
| uterus | 11% | 44.58 | 19 / 170 | 2% | 0.18 | 9 / 459 |
| pancreas | 0% | 0 | 0 / 328 | 12% | 0.27 | 22 / 178 |
| esophagus | 8% | 31.95 | 122 / 1445 | 1% | 0.09 | 2 / 183 |
| skin | 0% | 0.61 | 3 / 1809 | 8% | 0.36 | 36 / 472 |
| stomach | 2% | 7.69 | 7 / 359 | 3% | 0.14 | 8 / 286 |
| ovary | 2% | 8.02 | 3 / 180 | 3% | 0.09 | 11 / 430 |
| adipose | 4% | 15.09 | 48 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 31.09 | 52 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 1% | 3.92 | 11 / 966 | 3% | 0.05 | 14 / 527 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.24 | 3 / 80 |
| lung | 0% | 0 | 0 / 578 | 3% | 0.09 | 34 / 1155 |
| heart | 1% | 4.22 | 11 / 861 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.02 | 6 / 504 |
| prostate | 0% | 1.00 | 1 / 245 | 0% | 0.03 | 2 / 502 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.06 | 2 / 406 |
| muscle | 0% | 0.41 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008038 | Biological process | neuron recognition |
| GO_0007155 | Biological process | cell adhesion |
| GO_0098552 | Cellular component | side of membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | OPCML |
| Protein name | Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1) OPCML protein Opioid binding protein/cell adhesion molecule-like Opioid binding protein/cell adhesion molecule-like preprotein isoform a (Opioid binding protein/cell adhesion molecule-like, isoform CRA_a) (cDNA FLJ76211, highly similar to Homo sapiens opioid binding protein/cell adhesion molecule-like(OPCML), mRNA) Opioid binding protein/cell adhesion molecule-like isoform d (cDNA, FLJ79172, highly similar to Opioid-binding protein/cell adhesion moleculeprecursor) |
| Synonyms | IGLON1 OBCAM hCG_1811667 |
| Description | FUNCTION: Binds opioids in the presence of acidic lipids; probably involved in cell contact. |
| Accessions | B2CZX3 Q14982 ENST00000524381.6 [Q14982-2] ENST00000374778.4 [Q14982-3] A8K0Y0 B7ZLQ0 ENST00000331898.11 [Q14982-1] ENST00000541867.6 [Q14982-4] Q6B0I4 |